Marktgröße, Bericht, Forschung, Nachfrage, Wert Und Prognoseanalyse Für Arzneimittelabgabe Bis 2029

Global Drug Delivery Market

Marktgröße in Milliarden USD

CAGR : 8.50 %

Prognosezeitraum	2022 –2029
Marktgröße (Basisjahr)	USD 1,458.19 Million
Marktgröße (Prognosejahr)	USD 2,800.61 Million
CAGR	8.50 %
Wichtige Marktteilnehmer	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Anfrage zur Freischaltung

>Globaler Markt für Arzneimittelverabreichung , nach Produkttyp (orale Arzneimittelverabreichung, pulmonale Arzneimittelverabreichung, injizierbare Arzneimittelverabreichung, ophthalmische Arzneimittelverabreichung, nasale Arzneimittelverabreichung, topische Arzneimittelverabreichung, implantierbare Arzneimittelverabreichung, transmukosale Arzneimittelverabreichung), Anwendung (Krebs, Diabetes, Atemwegserkrankungen, Herz-Kreislauf-Erkrankungen, sonstige), Endbenutzer (Krankenhäuser, Fachkliniken, häusliche Pflege, sonstige), Vertriebskanal (Krankenhausapotheke, Einzelhandelsapotheke, Online-Apotheke, sonstige) – Branchentrends und Prognose bis 2029.

Marktanalyse und Größe

In den letzten Jahren wird erwartet, dass der Markt für Arzneimittelverabreichung im Prognosezeitraum stark wachsen wird. Laut der Weltgesundheitsorganisation (WHO ) wird die Prävalenz chronischer Krankheiten bis Ende 2020 voraussichtlich um 57 % steigen. Der Wunsch der Gesundheitssysteme, sich stärker auf fortschrittliche Technologien zur Arzneimittelverabreichung zu konzentrieren, ist als Reaktion auf den Anstieg chronischer Krankheiten rapide gestiegen. Darüber hinaus wird zunehmend Wert auf Produktsicherheit, Wirksamkeit und Patientenfreundlichkeit gelegt. Der Markt für Arzneimittelverabreichung wird in den kommenden Jahren aufgrund der Nachfrage nach ausgefeilten Technologien wachsen, um die steigende Nachfrage nach routinemäßig injizierbaren Arzneimitteln zur Behandlung chronischer Krankheiten zu decken.

Data Bridge Market Research analysiert, dass der Markt für Arzneimittelverabreichung im Jahr 2021 einen Wert von 1.458,19 Millionen USD hatte und bis 2029 voraussichtlich 2.800,61 Millionen USD erreichen wird, was einer durchschnittlichen jährlichen Wachstumsrate von 8,50 % während des Prognosezeitraums von 2022 bis 2029 entspricht. Der vom Data Bridge Market Research-Team zusammengestellte Marktbericht umfasst eine eingehende Expertenanalyse, Patientenepidemiologie, Pipeline-Analyse, Preisanalyse und regulatorische Rahmenbedingungen.

Marktdefinition

Die Verabreichung von Medikamenten bewirkt eine therapeutische Wirkung im menschlichen Körper, indem das Medikament an eine bestimmte Zielstelle abgegeben wird. Die Sicherheit und Wirksamkeit können durch Anpassung der Geschwindigkeit, Zeit und Freisetzung des Medikaments im Körper erhöht werden. Medikamente können auf verschiedene Arten verabreicht werden, darunter oral, injizierbar, pulmonal, nasal und andere Wege. Die Eigenschaften von Nanopartikeln wurden untersucht und zur Entwicklung von Medikamentenverabreichungssystemen genutzt, wodurch der Prozess der Medikamentenverteilung effizienter und zeitsparender wurde.

Berichtsumfang und Marktsegmentierung

Berichtsmetrik	Details
Prognosezeitraum	2022 bis 2029
Basisjahr	2021
Historische Jahre	2020 (Anpassbar auf 2019 – 2014)
Quantitative Einheiten	Umsatz in Mio. USD, Mengen in Einheiten, Preise in USD
Abgedeckte Segmente	Produkttyp (orale Arzneimittelverabreichung, pulmonale Arzneimittelverabreichung, injizierbare Arzneimittelverabreichung, ophthalmische Arzneimittelverabreichung, nasale Arzneimittelverabreichung, topische Arzneimittelverabreichung, implantierbare Arzneimittelverabreichung, transmukosale Arzneimittelverabreichung), Anwendung (Krebs, Diabetes, Atemwegserkrankungen, Herz-Kreislauf-Erkrankungen, Sonstige), Endverbraucher (Krankenhäuser, Fachkliniken, häusliche Pflege, Sonstige), Vertriebskanal (Krankenhausapotheke, Einzelhandelsapotheke, Online-Apotheke, Sonstige)
Abgedeckte Länder	USA, Kanada und Mexiko in Nordamerika, Deutschland, Frankreich, Großbritannien, Niederlande, Schweiz, Belgien, Russland, Italien, Spanien, Türkei, Restliches Europa in Europa, China, Japan, Indien, Südkorea, Singapur, Malaysia, Australien, Thailand, Indonesien, Philippinen, Restlicher Asien-Pazifik-Raum (APAC) in Asien-Pazifik (APAC), Saudi-Arabien, Vereinigte Arabische Emirate, Südafrika, Ägypten, Israel, Restlicher Naher Osten und Afrika (MEA) als Teil von Naher Osten und Afrika (MEA), Brasilien, Argentinien und Restliches Südamerika als Teil von Südamerika
Abgedeckte Marktteilnehmer	F. Hoffmann-La Roche Ltd. (Schweiz), Mylan NV (USA), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (Frankreich), Pfizer Inc. (USA), GlaxoSmithKline plc (Großbritannien), Novartis AG (Schweiz), Sun Pharmaceutical Industries Ltd. (Indien), Bausch Health Companies Inc. (Kanada), AstraZeneca (Großbritannien), Johnson & Johnson Private Limited (USA), Merck & Co., Inc. (USA), Cadila Pharmaceuticals. (Indien), Dr. Reddy's Laboratories Ltd. (Indien), 3M (USA), Bayer AG (Deutschland), Astellas Pharma Inc. (Japan), AbbVie Inc. (USA), Takeda Pharmaceutical Company Limited (Japan)
Marktchancen	Zunahme der Zahl der Schwellenmärkte Steigerung der Forschungs- und Entwicklungsaktivitäten Steigende Investitionen für die Entwicklung fortschrittlicher Technologien Innovative Produkteinführungen

Marktdynamik für Arzneimittelverabreichung

Treiber

Zunahme chronischer Erkrankungen

Die zunehmende Verbreitung chronischer Krankheiten wird das Wachstum des Arzneimittelmarktes voraussichtlich vorantreiben. Bewegungsarme Lebensweisen sind aufgrund der raschen technologischen Entwicklung alltäglich geworden. Die Fettleibigkeitsraten steigen infolge dieser Änderung des Lebensstils, was zu einer Reihe chronischer Leiden wie Diabetes und Herzkrankheiten führt.

Steigende Investitionen in die Gesundheitsinfrastruktur

Ein weiterer wichtiger Faktor, der die Wachstumsrate des Arzneimittelverabreichungsmarktes beeinflusst, sind die steigenden Gesundheitsausgaben, die zur Verbesserung der Infrastruktur beitragen.

Darüber hinaus werden zunehmende Initiativen öffentlicher und privater Organisationen zur Verbreitung des Bewusstseins und des technologischen Fortschritts den Arzneimittelverabreichungsmarkt erweitern. Darüber hinaus werden ein hohes verfügbares Einkommen und die zunehmende Einführung fortschrittlicher Arzneimittelverabreichungssysteme zu einer Expansion des Arzneimittelverabreichungsmarktes führen. Darüber hinaus werden die steigende Zahl geriatrischer Bevölkerungsgruppen und die steigende Nachfrage nach Biosimilars und Biologika die Wachstumsrate des Marktes steigern.

Gelegenheiten

Steigerung der Forschungs- und Entwicklungsaktivitäten

Darüber hinaus wird das Marktwachstum durch eine Zunahme der Forschungs- und Entwicklungsaktivitäten vorangetrieben. Dies wird dem Markt für Arzneimittelverabreichung günstige Wachstumschancen bieten. Darüber hinaus werden steigende Arzneimittelzulassungen und die Einführung innovativer Produkte das Marktwachstum weiter vorantreiben.

Darüber hinaus werden steigende Investitionen in die Entwicklung fortschrittlicher Technologien und eine Zunahme der Zahl aufstrebender Märkte im Prognosezeitraum weitere günstige Möglichkeiten für das Wachstum des Marktes für Arzneimittelverabreichung bieten.

Einschränkungen/Herausforderungen

Andererseits wird die steigende Zahl von Medikamentenrückrufen und Medikamentenversagen das Marktwachstum behindern. Der Mangel an qualifizierten Fachkräften und die fehlende Gesundheitsinfrastruktur in Entwicklungsländern werden den Arzneimittelverabreichungsmarkt vor Herausforderungen stellen. Darüber hinaus wird das Risiko von Nadelstichverletzungen das Marktwachstum im Prognosezeitraum 2022–2029 bremsen und weiter behindern.

Dieser Bericht zum Arzneimittelverabreichungsmarkt enthält Einzelheiten zu neuen Entwicklungen, Handelsvorschriften, Import-Export-Analysen, Produktionsanalysen, Wertschöpfungskettenoptimierungen, Marktanteilen, Auswirkungen inländischer und lokaler Marktteilnehmer, analysiert Chancen in Bezug auf neue Einnahmequellen, Änderungen der Marktvorschriften, strategische Marktwachstumsanalysen, Marktgröße, Kategoriemarktwachstum, Anwendungsnischen und -dominanz, Produktzulassungen, Produkteinführungen, geografische Expansionen und technologische Innovationen auf dem Markt. Um weitere Informationen zum Arzneimittelverabreichungsmarkt zu erhalten, wenden Sie sich an Data Bridge Market Research, um einen Analystenbericht zu erhalten. Unser Team hilft Ihnen dabei, eine fundierte Marktentscheidung zu treffen, um Marktwachstum zu erzielen.

Patientenepidemiologische Analyse

Der Arzneimittelverabreichungsmarkt bietet Ihnen auch detaillierte Marktanalysen für Patientenanalysen, Prognosen und Heilungen. Prävalenz, Inzidenz, Mortalität und Adhärenzraten sind einige der im Bericht verfügbaren Datenvariablen. Direkte oder indirekte Auswirkungsanalysen der Epidemiologie auf das Marktwachstum werden analysiert, um ein robusteres und kohortenbasiertes multivariates statistisches Modell zur Prognose des Marktes in der Wachstumsphase zu erstellen.

Auswirkungen von COVID-19 auf den Arzneimittelverabreichungsmarkt

Im Prognosezeitraum dürfte der Arzneimittelverabreichungsmarkt durch den COVID-19-Ausbruch eingeschränkt werden. Seit seinem Auftreten im Dezember 2019 hat sich das COVID-19- Virus in nahezu allen Ländern der Erde ausgebreitet, was die Weltgesundheitsorganisation (WHO) dazu veranlasste, es zu einem öffentlichen Gesundheitsnotfall zu erklären. COVID-19, ein neues Coronavirus, wurde als Auslöser der Lungenentzündungsfälle identifiziert. Dieses Virus verbreitete sich schnell auf der ganzen Welt und tötete eine große Zahl von Menschen. COVID-19 wurde im März 2020 von der Weltgesundheitsorganisation (WHO) als globale Pandemie bezeichnet und strenge Maßnahmen zur Verhinderung der Ausbreitung der Krankheit empfohlen. Seitdem hat die Pandemie den Ausbau des Gesundheitssektors verzögert und die Lieferkette unterbrochen. Darüber hinaus haben Regierungen in vielen Ländern landesweite Ausgangssperren verhängt, um die Ausbreitung von COVID-19 zu stoppen. In ähnlicher Weise haben Gesundheitsorganisationen in zahlreichen Ländern auf der ganzen Welt Schwierigkeiten, ihre Lieferkettenaktivitäten fortzusetzen. Die Langsamkeit der Lieferkette hat auch den Arzneimittelverabreichungsmarkt behindert.

Jüngste Entwicklung

Im März 2022 gab Sandoz, eine Division von Novartis, die Übernahme des in Großbritannien ansässigen Medizin- und Arzneimittelverabreichungsgeräteherstellers Coalesce Product Development Limited bekannt. Im Rahmen der Vereinbarung erwarb Sandoz das Fachwissen und die Vermögenswerte von Coalesce. Dies wird dem Unternehmen helfen, sein Portfolio an Atemwegsmedikamenten zu erweitern und den Zugang der Patienten zu hochwertigen, komplexen Therapeutika zu verbessern.

Globaler Marktumfang für Arzneimittelverabreichung

Der Markt für Arzneimittelverabreichung ist nach Produkttyp, Anwendung, Endnutzern und Vertriebskanal segmentiert. Das Wachstum dieser Segmente hilft Ihnen bei der Analyse schwacher Wachstumssegmente in den Branchen und bietet den Benutzern einen wertvollen Marktüberblick und Markteinblicke, die ihnen bei der strategischen Entscheidungsfindung zur Identifizierung der wichtigsten Marktanwendungen helfen.

Produkttyp

Orale Arzneimittelverabreichung
Pulmonale Arzneimittelverabreichung
Injizierbare Arzneimittelverabreichung
Ophthalmische Arzneimittelverabreichung
Nasale Arzneimittelverabreichung
Topische Arzneimittelverabreichung
Implantierbare Arzneimittelverabreichung
Transmukosale Arzneimittelverabreichung

Auf der Grundlage des Produkttyps ist der Markt in orale Arzneimittelverabreichung, pulmonale Arzneimittelverabreichung, injizierbare Arzneimittelverabreichung, ophthalmische Arzneimittelverabreichung, nasale Arzneimittelverabreichung, topische Arzneimittelverabreichung, implantierbare Arzneimittelverabreichung und transmukosale Arzneimittelverabreichung segmentiert.

Anwendung

Krebs
Diabetes
Atemwegserkrankungen
Herz-Kreislauf-Erkrankungen
Sonstiges

Je nach Anwendung ist der Markt in Krebs , Diabetes, Atemwegserkrankungen, Herz-Kreislauf-Erkrankungen und andere unterteilt.

Endbenutzer

Krankenhäuser
Spezialkliniken
Heimpflege
Sonstiges

Auf der Grundlage der Endverbraucher ist der Markt für die Arzneimittelabgabe in Krankenhäuser , Fachkliniken, häusliche Pflege und andere unterteilt.

Vertriebskanal

Krankenhausapotheke
Einzelhandelsapotheke
Online-Apotheke
Sonstiges

Auf der Grundlage der Vertriebskanäle wurde der Arzneimittelabgabemarkt außerdem in Krankenhausapotheken, Einzelhandelsapotheken, Online-Apotheken und andere segmentiert.

Regionale Analyse/Einblicke zum Arzneimittelverabreichungsmarkt

Der Markt für Arzneimittelverabreichung wird analysiert und es werden Einblicke in die Marktgröße und Trends nach Land, Produkttyp, Anwendung, Endbenutzern und Vertriebskanal wie oben angegeben bereitgestellt.

Die im Bericht zum Arzneimittelverabreichungsmarkt abgedeckten Länder sind die USA, Kanada und Mexiko in Nordamerika, Deutschland, Frankreich, Großbritannien, Niederlande, Schweiz, Belgien, Russland, Italien, Spanien, Türkei, Restliches Europa in Europa, China, Japan, Indien, Südkorea, Singapur, Malaysia, Australien, Thailand, Indonesien, Philippinen, Restlicher Asien-Pazifik-Raum (APAC) in Asien-Pazifik (APAC), Saudi-Arabien, Vereinigte Arabische Emirate, Südafrika, Ägypten, Israel, Restlicher Naher Osten und Afrika (MEA) als Teil von Naher Osten und Afrika (MEA), Brasilien, Argentinien und Restliches Südamerika als Teil von Südamerika

Nordamerika dominiert den Arzneimittelverabreichungsmarkt, da in dieser Region wichtige Schlüsselakteure vertreten sind und eine gut ausgebaute Gesundheitsinfrastruktur besteht. Darüber hinaus werden die zunehmende Verbreitung chronischer Krankheiten und die Entwicklung von Biologika und pharmazeutischen Arzneimitteln sowie Geräten das Marktwachstum in dieser Region weiter vorantreiben.

Im asiatisch-pazifischen Raum wird im Prognosezeitraum aufgrund der wachsenden geriatrischen Bevölkerung und der Möglichkeit der Selbstverwaltung in dieser Region ein Wachstum erwartet. Auch die Entwicklung der Gesundheitsinfrastruktur wird das Marktwachstum in dieser Region weiter vorantreiben.

Der Länderabschnitt des Berichts enthält auch Angaben zu einzelnen marktbeeinflussenden Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Trends des Marktes auswirken. Datenpunkte wie Downstream- und Upstream-Wertschöpfungskettenanalysen, technische Trends und Porters Fünf-Kräfte-Analyse sowie Fallstudien sind einige der Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Bereitstellung von Prognoseanalysen der Länderdaten werden auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen inländischer Zölle und Handelsrouten berücksichtigt.

Wettbewerbsumfeld und Analyse der Marktanteile im Bereich Arzneimittelverabreichung

Die Wettbewerbslandschaft des Arzneimittelverabreichungsmarktes liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, globale Präsenz, Produktionsstandorte und -anlagen, Produktionskapazitäten, Stärken und Schwächen des Unternehmens, Produkteinführung, Produktbreite und -umfang, Anwendungsdominanz. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus der Unternehmen in Bezug auf den Arzneimittelverabreichungsmarkt.

Zu den wichtigsten Akteuren auf dem Arzneimittelverabreichungsmarkt zählen:

F. Hoffmann-La Roche Ltd. (Schweiz)
Mylan NV (USA)
Teva Pharmaceutical Industries Ltd. (Israel)
Sanofi (Frankreich), Pfizer Inc. (USA)
GlaxoSmithKline plc (Großbritannien)
Novartis AG (Schweiz)
Sun Pharmaceutical Industries Ltd. (Indien)
Dr. Reddy's Laboratories Ltd. (Indien)
Bausch Health Companies Inc. (Kanada)
AstraZeneca (Großbritannien)
Johnson & Johnson Private Limited (USA)
Merck & Co., Inc. (USA)
Cadila Pharmaceuticals. (Indien)
3M (USA)
Bayer AG (Deutschland)
Astellas Pharma Inc. (Japan)
AbbVie Inc. (USA)
Takeda Pharmaceutical Company Limited (Japan)

SKU-52812

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Klicken Sie auf das Bild, um es zu vergrößern

Interaktives Datenanalyse-Dashboard
Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
Zugriff für Research-Analysten für Anpassungen und Abfragen
Konkurrenzanalyse mit interaktivem Dashboard
Aktuelle Nachrichten, Updates und Trendanalyse
Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung

Demo anfordern

Inhaltsverzeichnis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL DRUG DELIVERY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISING PREVALENCE OF CHRONIC DISEASE AND NON CHRONIC DISEASE

5.1.2 GROWTH IN THE DEVELOPMENT OF BIOLOGICS

5.1.3 TECHNOLOGICAL DEVELOPMENT

5.1.4 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT

5.1.5 RISING ACCEPTANCE OF SELF ADMINISTERING DRUGS

5.2 RESTRAINTS

5.2.1 RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS

5.2.2 HIGH COSTS OF DRUGS

5.2.3 STRINGENT REGULATORY SCENARIO

5.2.4 PRODUCT RECALLS

5.3 OPPORTUNITIES

5.3.1 RISING DEMAND FOR BIOSIMILARS AND GENERIC DRUGS

5.3.2 THERAPEUTIC ADVANCEMENTS

5.3.3 TREND OF MERGER AND ACQUISITIONS AND COLLABORATIONS

5.3.4 FOCUS ON PATIENTS’ NEEDS

5.3.5 DEVELOPING AND NEW EMERGING REVENUE POCKETS

5.4 CHALLENGES

5.4.1 SIDE EFFECTS OF DRUG DELIVERY SYSTEMS

5.4.2 PATENT EXPIRY AND PATENT CLIFF

5.4.3 ALTERNATIVES TO DRUG DELIVERY

6 GLOBAL DRUG DELIVERY MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 ORAL DRUG DELIVERY

6.2.1 BY FORM

6.2.1.1 SOLID ORAL DRUGS

6.2.1.1.1 TABLETS

6.2.1.1.2 CAPSULES

6.2.1.1.3 PILLS

6.2.1.1.4 POWDERS

6.2.1.2 LIQUID ORAL DRUGS

6.2.1.2.1 SYRUPS

6.2.1.2.2 SOLUTIONS

6.2.1.3 semi solid oral drugs

6.2.1.3.1 GELS

6.2.1.3.2 EMULSIONS

6.2.1.3.3 ELIXIRS

6.3 INJECTABLE DRUG DELIVERY

6.3.1 INJECTABLE DRUG DELIVERY DEVICES

6.3.1.1 CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES

6.3.1.1.1 BY MATERIAL TYPE

6.3.1.1.1.1 GLASS

6.3.1.1.1.2 PLASTIC

6.3.1.1.2 BY PRODUCT TYPE

6.3.1.1.2.1 FILLABLE

6.3.1.1.2.2 PRE-FILLED

6.3.1.1.3 BY USABILITY

6.3.1.1.3.1 REUSABLE SYRINGES

6.3.1.1.3.2 DISPOSABLE SYRINGES

6.3.1.2 SELF-INJECTION DRUG DELIVERY

6.3.1.2.1 NEEDLE FREE INJECTORS

6.3.1.2.2 WEARABLE INJECTORS

6.3.1.2.3 PEN INJECTOR

6.3.1.2.4 AUTO INJECTORS

6.3.1.2.5 OTHERS

6.3.2 INJECTABLE DRUG DELIVERY FORMULATIONS

6.3.2.1 CONVENTIONAL DRUG DELIVERY FORMULATIONS

6.3.2.2 NOVEL DRUG DELIVERY FORMULATIONS

6.3.2.3 LONG ACTING INJECTION FORMULATIONS

6.4 OPHTHALMIC DRUG DELIVERY

6.4.1.1 OCULAR DRUG DELIVERY FORMULATIONS

6.4.1.1.1 LIQUID OCULAR DRUG DELIVERY FORMULATIONS

6.4.1.1.1.1 SOLUTIONS

6.4.1.1.1.2 SUSPENSIONS

6.4.1.1.2 SEMI SOLID OCULAR DRUG DELIVERY FORMULATIONS

6.4.1.1.2.1 GELS

6.4.1.1.2.2 OINTMENTS

6.4.1.2 OCULAR DRUG DELIVERY DEVICES

6.4.1.2.1.1 DRUG COATED CONTACT LENSES

6.4.1.2.1.2 OCULAR INSERTS

6.5 NASAL DRUG DELIVERY

6.5.1 NASAL DROPS

6.5.2 NASAL SPRAYS

6.5.3 NASAL POWDERS

6.5.4 NASAL GELS

6.6 TOPICAL DRUG DELIVERY

6.6.1 TRANSDERMAL DRUG DELIVERY DEVICES

6.6.1.1 TRANSDERMAL PATCHES

6.6.1.2 TRANSDERMAL GELS

6.6.2 TRANSDERMAL DRUG DELIVERY FORMULATIONS

6.6.2.1 LIQUID TOPICAL DRUG DELIVERY FORMULATIONS

6.6.2.1.1 SUSPENSIONS

6.6.2.1.2 SOLUTIONS

6.6.2.2 SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS

6.6.2.2.1 OINTMENTS

6.6.2.2.2 CREAMS

6.6.2.2.3 LOTIONS

6.6.2.2.4 GELS

6.6.2.2.5 PASTES

6.6.2.3 SOLID TOPICAL DRUG DELIVERY FORMULATIONS

6.6.2.3.1 POWDER

6.6.2.3.2 SUPPOSITORS

6.7 IMPLANTABLE DRUG DELIVERY

6.7.1 PASSIVE IMPLANTABLE DRUG DELIVERY DEVICES

6.7.2 ACTIVE IMPLANTABLE DRUG DELIVERY DEVICES

6.8 TRANSMUCOSAL DRUG DELIVERY

6.8.1 ORAL TRANSMUCOSAL DRUG DELIVERY

6.8.1.1 BUCCAL DRUG DELIVERY

6.8.1.2 SUBLINGUAL DRUG DELIVERY

6.8.2 OTHER TRANSMUCOSAL DRUG DELIVERY

6.8.2.1 RECTAL TRANSMUCOSAL DRUG DELIVERY

6.8.2.2 VAGINAL TRANSMUCOSAL DRUG DELIVERY

6.9 PULMONARY DRUG DELIVERY

6.9.1 METERED DOSE INHALERS (MDI)

6.9.2 DRY POWDER INHALERS (DPI)

6.9.3 NEBULIZERS

6.9.3.1 JET NEBULIZERS

6.9.3.2 ULTRASONIC NEBULIZERS

6.9.3.3 SOFT MIST NEBULIZERS

7 GLOBAL DRUG DELIVERY MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITALS

7.3 HOME HEALTHCARE

7.4 CLINICS

7.5 COMMUNITY HEALTHCARE

7.6 OTHERS

8 GLOBAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW

8.2 DIRECT TENDERS

8.3 HOSPITAL PHARMACIES

8.4 PHARMACY STORES

8.5 ONLINE PHARMACY

9 GLOBAL DRUG DELIVERY MARKET, BY GEOGRAPHY

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 U.S.

9.2.2 CANADA

9.2.3 MEXICO

9.3 EUROPE

9.3.1 GERMANY

9.3.2 FRANCE

9.3.3 ITALY

9.3.4 U.K.

9.3.5 SWITZERLAND

9.3.6 SPAIN

9.3.7 NETHERLANDS

9.3.8 RUSSIA

9.3.9 TURKEY

9.3.10 BELGIUM

9.3.11 REST OF EUROPE

9.4 ASIA-PACIFIC

9.4.1 JAPAN

9.4.2 CHINA

9.4.3 INDIA

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 THAILAND

9.4.7 MALAYSIA

9.4.8 SINGAPORE

9.4.9 INDONESIA

9.4.10 PHILIPPINES

9.4.11 REST OF ASIA-PACIFIC

9.5 SOUTH AMERICA

9.5.1 BRAZIL

9.5.2 REST OF SOUTH AMERICA

9.6 MIDDLE EAST AND AFRICA

9.6.1 SOUTH AFRICA

9.6.2 REST OF MIDDLE EAST AND AFRICA

10 GLOBAL DRUG DELIVERY MARKET, COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: GLOBAL

10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

10.3 COMPANY SHARE ANALYSIS: EUROPE

10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11 COMPANY PROFILES

11.1 JOHNSON & JOHNSON SERVICES, INC.

11.1.1 COMPANY SNAPSHOT

11.1.2 REVENUE ANALYSIS

11.1.3 COMPANY SHARE ANALYSIS

11.1.4 PRODUCT PORTFOLIO

11.1.5 RECENT DEVELOPMENTS

11.2 NOVARTIS AG

11.2.1 COMPANY SNAPSHOT

11.2.2 REVENUE ANALYSIS

11.2.3 COMPANY SHARE ANALYSIS

11.2.4 PRODUCT PORTFOLIO

11.2.5 RECENT DEVELOPMENTS

11.3 F. HOFFMANN-LA ROCHE LTD

11.3.1 COMPANY SNAPSHOT

11.3.2 REVENUE ANALYSIS

11.3.3 COMPANY SHARE ANALYSIS

11.3.4 PRODUCT PORTFOLIO

11.3.5 RECENT DEVELOPMENTS

11.4 BAYER AG

11.4.1 COMPANY SNAPSHOT

11.4.2 REVENUE ANALYSIS

11.4.3 COMPANY SHARE ANALYSIS

11.4.4 PRODUCT PORTFOLIO

11.4.5 RECENT DEVELOPMENTS

11.5 PFIZER INC.

11.5.1 COMPANY SNAPSHOT

11.5.2 REVENUE ANALYSIS

11.5.3 COMPANY SHARE ANALYSIS

11.5.4 BRAND PORTFOLIO

11.5.5 RECENT DEVELOPMENTS

11.6 3M

11.6.1 COMPANY SNAPSHOT

11.6.2 REVENUE ANALYSIS

11.6.3 PRODUCT PORTFOLIO

11.6.4 RECENT DEVELOPMENTS

11.7 ANTARES PHARMA

11.7.1 COMPANY SNAPSHOT

11.7.2 REVENUE ANALYSIS

11.7.3 PRODUCT PORTFOLIO

11.7.4 RECENT DEVELOPMENTS

11.8 GLAXOSMITHKLINE PLC

11.8.1 COMPANY SNAPSHOT

11.8.2 REVENUE ANALYSIS

11.8.3 PRODUCT PORTFOLIO

11.8.4 RECENT DEVELOPMENTS

11.9 MERCK SHARP & DOHME CORP. (A SUBSIDIARY OF MERCK & CO., INC.)

11.9.1 COMPANY SNAPSHOT

11.9.2 REVENUE ANALYSIS

11.9.3 PRODUCT PORTFOLIO

11.9.4 RECENT DEVELOPMENTS

11.1 NEMERA

11.10.1 COMPANY SNAPSHOT

11.10.2 PRODUCT PORTFOLIO

11.10.3 RECENT DEVELOPMENTS

11.11 SANOFI

11.11.1 COMPANY SNAPSHOT

11.11.2 REVENUE ANALYSIS

11.11.3 PRODUCT PORTFOLIO

11.11.4 RECENT DEVELOPMENTS

12 QUESTIONNAIRE

13 RELATED REPORTS

Tabellenverzeichnis

TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2016

TABLE 2 10 MOST EXPENSIVE DRUGS IN THE U.S.

TABLE 3 MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY MARKET, 2019-2020

TABLE 4 LIST OF FDA APPROVED GENERICS, IN 2019

TABLE 5 PATENT EXPIRY OF DRUGS, 2019

TABLE 6 GLOBAL DRUG DELIVERY MARKET, BY PRODUCT TYPE , 2018-2027 (USD BILLION)

TABLE 7 GLOBAL ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 8 GLOBAL ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 9 GLOBAL SOLID ORAL DRUG IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 10 GLOBAL LIQUID ORAL DRUG IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 11 GLOBAL SEMI SOLID ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 12 GLOBAL INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 13 GLOBAL INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 14 GLOBAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 15 GLOBAL CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 16 GLOBAL CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 17 GLOBAL CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 18 GLOBAL SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 19 GLOBAL INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 20 GLOBAL OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 21 GLOBAL OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 22 GLOBAL OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 23 GLOBAL LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 24 GLOBAL SEMI SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 25 GLOBAL OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 26 GLOBAL NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 27 GLOBAL NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 28 GLOBAL TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 29 GLOBAL TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 30 GLOBAL TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 31 GLOBAL TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 32 GLOBAL LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 33 GLOBAL SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 34 GLOBAL SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 35 GLOBAL IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 36 GLOBAL IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 37 GLOBAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 38 GLOBAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 39 GLOBAL ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 40 GLOBAL OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 41 GLOBAL PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 42 GLOBAL PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 43 GLOBAL NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 44 GLOBAL DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 45 GLOBAL HOPITALS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 46 GLOBAL HOME HEALTHCARE IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 47 GLOBAL CLINICS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 48 GLOBAL COMMUNITY HEALTHCARE IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 49 GLOBAL OTHERS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 50 GLOBAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 51 GLOBAL DIRECT TENDERS IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 52 GLOBAL HOSPITAL PHARMACIES IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 53 GLOBAL PHARMACY STORES IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 54 GLOBAL ONLINE PHARMACY IN DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 55 GLOBAL DRUG DELIVERY MARKET, BY REGION, 2018-2027 (USD BILLION)

TABLE 56 NORTH AMERICA DRUG DELIVERY MARKET, BY COUNTRY, 2020-2027 (USD BILLION)

TABLE 57 NORTH AMERICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2020-2027 (USD BILLION)

TABLE 58 NORTH AMERICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 59 NORTH AMERICA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 60 NORTH AMERICA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 61 NORTH AMERICA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 62 NORTH AMERICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 63 NORTH AMERICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 64 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 65 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 66 NORTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 67 NORTH AMERICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 68 NORTH AMERICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 69 NORTH AMERICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 70 NORTH AMERICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 71 NORTH AMERICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 72 NORTH AMERICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 73 NORTH AMERICA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 74 NORTH AMERICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 75 NORTH AMERICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 76 NORTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 77 NORTH AMERICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 78 NORTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 79 NORTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 80 NORTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 81 NORTH AMERICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 82 NORTH AMERICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 83 NORTH AMERICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 84 NORTH AMERICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 85 NORTH AMERICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 86 NORTH AMERICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 87 NORTH AMERICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 88 NORTH AMERICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 89 U.S. DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 90 U.S. ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 91 U.S. SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 92 U.S. LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 93 U.S. SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 94 U.S. INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 95 U.S. INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 96 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 97 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 98 U.S. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 99 U.S. SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 100 U.S. INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 101 U.S. OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 102 U.S. OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 103 U.S. OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 104 U.S. LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 105 U.S. SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 106 U.S. NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 107 U.S. TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 108 U.S. TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 109 U.S. TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 110 U.S. SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 111 U.S. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 112 U.S. SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 113 U.S. IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 114 U.S. TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 115 U.S. ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 116 U.S. OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 117 U.S. PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 118 U.S. NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 119 U.S. DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 120 U.S. DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 121 CANADA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2020-2027 (USD BILLION)

TABLE 122 CANADA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 123 CANADA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 124 CANADA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 125 CANADA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 126 CANADA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 127 CANADA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 128 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 129 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 130 CANADA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 131 CANADA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 132 CANADA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 133 CANADA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 134 CANADA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 135 CANADA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 136 CANADA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 137 CANADA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 138 CANADA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 139 CANADA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 140 CANADA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 141 CANADA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 142 CANADA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 143 CANADA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 144 CANADA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 145 CANADA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 146 CANADA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 147 CANADA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 148 CANADA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 149 CANADA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 150 CANADA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 151 CANADA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 152 CANADA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 153 MEXICO DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2020-2027 (USD BILLION)

TABLE 154 MEXICO ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 155 MEXICO SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 156 MEXICO LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 157 MEXICO SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 158 MEXICO INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 159 MEXICO INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 160 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 161 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 162 MEXICO CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 163 MEXICO SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 164 MEXICO INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 165 MEXICO OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 166 MEXICO OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 167 MEXICO OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 168 MEXICO LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 169 MEXICO SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 170 MEXICO NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 171 MEXICO TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 172 MEXICO TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 173 MEXICO TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 174 MEXICO SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 175 MEXICO LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 176 MEXICO SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 177 MEXICO IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 178 MEXICO TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 179 MEXICO ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 180 MEXICO OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 181 MEXICO PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 182 MEXICO NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 183 MEXICO DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 184 MEXICO DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 185 EUROPE DRUG DELIVERY MARKET, BY COUNTRY, 2018-2027 (USD BILLION)

TABLE 186 EUROPE DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 187 EUROPE ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 188 EUROPE SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 189 EUROPE LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 190 EUROPE SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 191 EUROPE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 192 EUROPE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 193 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 194 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 195 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 196 EUROPE SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 197 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 198 EUROPE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 199 EUROPE OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 200 EUROPE OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 201 EUROPE LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 202 EUROPE SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 203 EUROPE NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 204 EUROPE TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 205 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 206 EUROPE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 207 EUROPE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 208 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 209 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 210 EUROPE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 211 EUROPE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 212 EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 213 EUROPE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 214 EUROPE PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 215 EUROPE NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 216 EUROPE DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 217 EUROPE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 218 GERMANY DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 219 GERMANY ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 220 GERMANY SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 221 GERMANY LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 222 GERMANY SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 223 GERMANY INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 224 GERMANY INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 225 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 226 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 227 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 228 GERMANY SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 229 GERMANY INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 230 GERMANY OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 231 GERMANY OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 232 GERMANY OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 233 GERMANY LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 234 GERMANY SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 235 GERMANY NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 236 GERMANY TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 237 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 238 GERMANY TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 239 GERMANY SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 240 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 241 GERMANY SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 242 GERMANY IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 243 GERMANY TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 244 GERMANY ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 245 GERMANY OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 246 GERMANY PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 247 GERMANY NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 248 GERMANY DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 249 GERMANY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 250 FRANCE DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 251 FRANCE ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 252 FRANCE SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 253 FRANCE LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 254 FRANCE SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 255 FRANCE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 256 FRANCE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 257 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 258 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 259 FRANCE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 260 FRANCE SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 261 FRANCE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 262 FRANCE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 263 FRANCE OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 264 FRANCE OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 265 FRANCE LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 266 FRANCE SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 267 FRANCE NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 268 FRANCE TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 269 FRANCE TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 270 FRANCE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 271 FRANCE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 272 FRANCE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 273 FRANCE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 274 FRANCE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 275 FRANCE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 276 FRANCE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 277 FRANCE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 278 FRANCE PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 279 FRANCE NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 280 FRANCE DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 281 FRANCE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 282 ITALY DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 283 ITALY ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 284 ITALY SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 285 ITALY LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 286 ITALY SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 287 ITALY INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 288 ITALY INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 289 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 290 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 291 ITALY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 292 ITALY SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 293 ITALY INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 294 ITALY OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 295 ITALY OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 296 ITALY OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 297 ITALY LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 298 ITALY SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 299 ITALY NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 300 ITALY TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 301 ITALY TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 302 ITALY TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 303 ITALY SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 304 ITALY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 305 ITALY SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 306 ITALY IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 307 ITALY TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 308 ITALY ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 309 ITALY OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 310 ITALY PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 311 ITALY NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 312 ITALY DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 313 ITALY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 314 U.K. DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 315 U.K. ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 316 U.K. SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 317 U.K. LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 318 U.K. SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 319 U.K. INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 320 U.K. INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 321 U.K. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 322 U.K. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 323 U.K. CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 324 U.K. SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 325 U.K. INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 326 U.K. OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 327 U.K. OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 328 U.K. OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 329 U.K. LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 330 U.K. SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 331 U.K. NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 332 U.K. TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 333 U.K. TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 334 U.K. TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 335 U.K. SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 336 U.K. LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 337 U.K. SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 338 U.K. IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 339 U.K. TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 340 U.K. ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 341 U.K. OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 342 U.K. PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 343 U.K. NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 344 U.K. DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 345 U.K. DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 346 SWITZERLAND DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 347 SWITZERLAND ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 348 SWITZERLAND SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 349 SWITZERLAND LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 350 SWITZERLAND SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 351 SWITZERLAND INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 352 SWITZERLAND INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 353 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 354 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 355 SWITZERLAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 356 SWITZERLAND SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 357 SWITZERLAND INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 358 SWITZERLAND OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 359 SWITZERLAND OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 360 SWITZERLAND OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 361 SWITZERLAND LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 362 SWITZERLAND SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 363 SWITZERLAND NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 364 SWITZERLAND TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 365 SWITZERLAND TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 366 SWITZERLAND TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 367 SWITZERLAND SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 368 SWITZERLAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 369 SWITZERLAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 370 SWITZERLAND IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 371 SWITZERLAND TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 372 SWITZERLAND ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 373 SWITZERLAND OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 374 SWITZERLAND PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 375 SWITZERLAND NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 376 SWITZERLAND DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 377 SWITZERLAND DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 378 SPAIN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 379 SPAIN ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 380 SPAIN SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 381 SPAIN LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 382 SPAIN SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 383 SPAIN INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 384 SPAIN INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 385 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 386 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 387 SPAIN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 388 SPAIN SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 389 SPAIN INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 390 SPAIN OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 391 SPAIN OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 392 SPAIN OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 393 SPAIN LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 394 SPAIN SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 395 SPAIN NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 396 SPAIN TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 397 SPAIN TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 398 SPAIN TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 399 SPAIN SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 400 SPAIN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 401 SPAIN SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 402 SPAIN IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 403 SPAIN TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 404 SPAIN ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 405 SPAIN OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 406 SPAIN PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 407 SPAIN NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 408 SPAIN DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 409 SPAIN DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 410 NETHERLANDS DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 411 NETHERLANDS ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 412 NETHERLANDS SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 413 NETHERLANDS LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 414 NETHERLANDS SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 415 NETHERLANDS INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 416 NETHERLANDS INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 417 NETHERLANDS CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 418 NETHERLANDS CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 419 NETHERLANDS CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 420 NETHERLANDS SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 421 NETHERLANDS INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 422 NETHERLANDS OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 423 NETHERLANDS OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 424 NETHERLANDS OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 425 NETHERLANDS LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 426 NETHERLANDS SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 427 NETHERLANDS NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 428 NETHERLANDS TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 429 NETHERLANDS TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 430 NETHERLANDS TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 431 NETHERLANDS SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 432 NETHERLANDS LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 433 NETHERLANDS SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 434 NETHERLANDS IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 435 NETHERLANDS TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 436 NETHERLANDS ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 437 NETHERLANDS OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 438 NETHERLANDS PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 439 NETHERLANDS NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 440 NETHERLANDS DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 441 NETHERLANDS DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 442 RUSSIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 443 RUSSIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 444 RUSSIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 445 RUSSIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 446 RUSSIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 447 RUSSIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 448 RUSSIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 449 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 450 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 451 RUSSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 452 RUSSIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 453 RUSSIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 454 RUSSIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 455 RUSSIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 456 RUSSIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 457 RUSSIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 458 RUSSIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 459 RUSSIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 460 RUSSIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 461 RUSSIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 462 RUSSIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 463 RUSSIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 464 RUSSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 465 RUSSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 466 RUSSIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 467 RUSSIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 468 RUSSIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 469 RUSSIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 470 RUSSIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 471 RUSSIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 472 RUSSIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 473 RUSSIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 474 TURKEY DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 475 TURKEY ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 476 TURKEY SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 477 TURKEY LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 478 TURKEY SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 479 TURKEY INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 480 TURKEY INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 481 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 482 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 483 TURKEY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 484 TURKEY SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 485 TURKEY INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 486 TURKEY OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 487 TURKEY OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 488 TURKEY OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 489 TURKEY LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 490 TURKEY SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 491 TURKEY NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 492 TURKEY TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 493 TURKEY TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 494 TURKEY TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 495 TURKEY SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 496 TURKEY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 497 TURKEY SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 498 TURKEY IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 499 TURKEY TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 500 TURKEY ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 501 TURKEY OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 502 TURKEY PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 503 TURKEY NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 504 TURKEY DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 505 TURKEY DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 506 BELGIUM DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 507 BELGIUM ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 508 BELGIUM SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 509 BELGIUM LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 510 BELGIUM SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 511 BELGIUM INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 512 BELGIUM INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 513 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 514 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 515 BELGIUM CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 516 BELGIUM SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 517 BELGIUM INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 518 BELGIUM OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 519 BELGIUM OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 520 BELGIUM OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 521 BELGIUM LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 522 BELGIUM SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 523 BELGIUM NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 524 BELGIUM TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 525 BELGIUM TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 526 BELGIUM TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 527 BELGIUM SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 528 BELGIUM LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 529 BELGIUM SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 530 BELGIUM IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 531 BELGIUM TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 532 BELGIUM ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 533 BELGIUM OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 534 BELGIUM PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 535 BELGIUM NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 536 BELGIUM DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 537 BELGIUM DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 538 REST OF EUROPE DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 539 ASIA-PACIFIC DRUG DELIVERY MARKET, BY COUNTRY, 2018-2027 (USD BILLION)

TABLE 540 ASIA-PACIFIC DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 541 ASIA-PACIFIC ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 542 ASIA-PACIFIC SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 543 ASIA-PACIFIC LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 544 ASIA-PACIFIC SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 545 ASIA-PACIFIC INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 546 ASIA-PACIFIC INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 547 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 548 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 549 ASIA-PACIFIC CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 550 ASIA-PACIFIC SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 551 ASIA-PACIFIC INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 552 ASIA-PACIFIC OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 553 ASIA-PACIFIC OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 554 ASIA-PACIFIC OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 555 ASIA-PACIFIC LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 556 ASIA-PACIFIC SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 557 ASIA-PACIFIC NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 558 ASIA-PACIFIC TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 559 ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 560 ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 561 ASIA-PACIFIC SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 562 ASIA-PACIFIC LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 563 ASIA-PACIFIC SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 564 ASIA-PACIFIC IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 565 ASIA-PACIFIC TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 566 ASIA-PACIFIC ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 567 ASIA-PACIFIC OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 568 ASIA-PACIFIC PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 569 ASIA-PACIFIC NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 570 ASIA-PACIFIC DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 571 ASIA-PACIFIC DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 572 JAPAN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 573 JAPAN ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 574 JAPAN SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 575 JAPAN LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 576 JAPAN SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 577 JAPAN INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 578 JAPAN INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 579 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 580 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 581 JAPAN CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 582 JAPAN SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 583 JAPAN INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 584 JAPAN OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 585 JAPAN OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 586 JAPAN OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 587 JAPAN LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 588 JAPAN SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 589 JAPAN NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 590 JAPAN TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 591 JAPAN TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 592 JAPAN TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 593 JAPAN SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 594 JAPAN LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 595 JAPAN SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 596 JAPAN IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 597 JAPAN TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 598 JAPAN ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 599 JAPAN OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 600 JAPAN PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 601 JAPAN NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 602 JAPAN DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 603 JAPAN DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 604 CHINA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 605 CHINA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 606 CHINA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 607 CHINA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 608 CHINA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 609 CHINA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 610 CHINA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 611 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 612 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 613 CHINA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 614 CHINA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 615 CHINA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 616 CHINA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 617 CHINA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 618 CHINA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 619 CHINA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 620 CHINA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 621 CHINA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 622 CHINA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 623 CHINA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 624 CHINA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 625 CHINA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 626 CHINA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 627 CHINA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 628 CHINA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 629 CHINA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 630 CHINA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 631 CHINA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 632 CHINA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 633 CHINA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 634 CHINA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 635 CHINA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 636 INDIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 637 INDIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 638 INDIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 639 INDIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 640 INDIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 641 INDIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 642 INDIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 643 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 644 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 645 INDIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 646 INDIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 647 INDIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 648 INDIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 649 INDIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 650 INDIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 651 INDIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 652 INDIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 653 INDIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 654 INDIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 655 INDIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 656 INDIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 657 INDIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 658 INDIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 659 INDIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 660 INDIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 661 INDIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 662 INDIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 663 INDIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 664 INDIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 665 INDIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 666 INDIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 667 INDIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 668 SOUTH KOREA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 669 SOUTH KOREA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 670 SOUTH KOREA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 671 SOUTH KOREA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 672 SOUTH KOREA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 673 SOUTH KOREA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 674 SOUTH KOREA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 675 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 676 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 677 SOUTH KOREA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 678 SOUTH KOREA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 679 SOUTH KOREA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 680 SOUTH KOREA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 681 SOUTH KOREA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 682 SOUTH KOREA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 683 SOUTH KOREA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 684 SOUTH KOREA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 685 SOUTH KOREA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 686 SOUTH KOREA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 687 SOUTH KOREA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 688 SOUTH KOREA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 689 SOUTH KOREA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 690 SOUTH KOREA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 691 SOUTH KOREA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 692 SOUTH KOREA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 693 SOUTH KOREA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 694 SOUTH KOREA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 695 SOUTH KOREA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 696 SOUTH KOREA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 697 SOUTH KOREA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 698 SOUTH KOREA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 699 SOUTH KOREA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 700 AUSTRALIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 701 AUSTRALIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 702 AUSTRALIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 703 AUSTRALIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 704 AUSTRALIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 705 AUSTRALIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 706 AUSTRALIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 707 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 708 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 709 AUSTRALIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 710 AUSTRALIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 711 AUSTRALIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 712 AUSTRALIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 713 AUSTRALIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 714 AUSTRALIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 715 AUSTRALIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 716 AUSTRALIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 717 AUSTRALIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 718 AUSTRALIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 719 AUSTRALIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 720 AUSTRALIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 721 AUSTRALIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 722 AUSTRALIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 723 AUSTRALIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 724 AUSTRALIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 725 AUSTRALIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 726 AUSTRALIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 727 AUSTRALIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 728 AUSTRALIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 729 AUSTRALIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 730 AUSTRALIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 731 AUSTRALIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 732 THAILAND DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 733 THAILAND ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 734 THAILAND SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 735 THAILAND LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 736 THAILAND SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 737 THAILAND INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 738 THAILAND INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 739 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 740 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 741 THAILAND CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 742 THAILAND SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 743 THAILAND INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 744 THAILAND OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 745 THAILAND OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 746 THAILAND OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 747 THAILAND LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 748 THAILAND SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 749 THAILAND NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 750 THAILAND TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 751 THAILAND TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 752 THAILAND TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 753 THAILAND SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 754 THAILAND LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 755 THAILAND SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 756 THAILAND IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 757 THAILAND TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 758 THAILAND ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 759 THAILAND OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 760 THAILAND PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 761 THAILAND NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 762 THAILAND DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 763 THAILAND DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 764 MALAYSIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 765 MALAYSIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 766 MALAYSIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 767 MALAYSIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 768 MALAYSIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 769 MALAYSIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 770 MALAYSIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 771 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 772 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 773 MALAYSIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 774 MALAYSIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 775 MALAYSIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 776 MALAYSIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 777 MALAYSIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 778 MALAYSIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 779 MALAYSIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 780 MALAYSIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 781 MALAYSIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 782 MALAYSIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 783 MALAYSIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 784 MALAYSIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 785 MALAYSIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 786 MALAYSIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 787 MALAYSIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 788 MALAYSIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 789 MALAYSIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 790 MALAYSIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 791 MALAYSIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 792 MALAYSIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 793 MALAYSIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 794 MALAYSIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 795 MALAYSIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 796 SINGAPORE DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 797 SINGAPORE ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 798 SINGAPORE SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 799 SINGAPORE LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 800 SINGAPORE SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 801 SINGAPORE INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 802 SINGAPORE INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 803 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 804 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 805 SINGAPORE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 806 SINGAPORE SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 807 SINGAPORE INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 808 SINGAPORE OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 809 SINGAPORE OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 810 SINGAPORE OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 811 SINGAPORE LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 812 SINGAPORE SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 813 SINGAPORE NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 814 SINGAPORE TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 815 SINGAPORE TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 816 SINGAPORE TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 817 SINGAPORE SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 818 SINGAPORE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 819 SINGAPORE SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 820 SINGAPORE IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 821 SINGAPORE TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 822 SINGAPORE ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 823 SINGAPORE OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 824 SINGAPORE PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 825 SINGAPORE NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 826 SINGAPORE DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 827 SINGAPORE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 828 INDONESIA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 829 INDONESIA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 830 INDONESIA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 831 INDONESIA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 832 INDONESIA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 833 INDONESIA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 834 INDONESIA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 835 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 836 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 837 INDONESIA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 838 INDONESIA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 839 INDONESIA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 840 INDONESIA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 841 INDONESIA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 842 INDONESIA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 843 INDONESIA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 844 INDONESIA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 845 INDONESIA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 846 INDONESIA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 847 INDONESIA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 848 INDONESIA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 849 INDONESIA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 850 INDONESIA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 851 INDONESIA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 852 INDONESIA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 853 INDONESIA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 854 INDONESIA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 855 INDONESIA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 856 INDONESIA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 857 INDONESIA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 858 INDONESIA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 859 INDONESIA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 860 PHILLIPINES DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 861 PHILLIPINES ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 862 PHILLIPINES SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 863 PHILLIPINES LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 864 PHILLIPINES SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 865 PHILLIPINES INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 866 PHILLIPINES INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 867 PHILLIPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 868 PHILLIPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 869 PHILLIPINES CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 870 PHILLIPINES SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 871 PHILLIPINES INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 872 PHILLIPINES OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 873 PHILLIPINES OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 874 PHILLIPINES OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 875 PHILLIPINES LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 876 PHILLIPINES SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 877 PHILLIPINES NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 878 PHILLIPINES TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 879 PHILLIPINES TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 880 PHILLIPINES TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 881 PHILLIPINES SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 882 PHILLIPINES LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 883 PHILLIPINES SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 884 PHILLIPINES IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 885 PHILLIPINES TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 886 PHILLIPINES ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 887 PHILLIPINES OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 888 PHILLIPINES PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 889 PHILLIPINES NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 890 PHILLIPINES DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 891 PHILLIPINES DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 892 REST OF ASIA-PACIFIC DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 893 SOUTH AMERICA DRUG DELIVERY MARKET, BY COUNTRY, 2018-2027 (USD BILLION)

TABLE 894 SOUTH AMERICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 895 SOUTH AMERICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 896 SOUTH AMERICA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 897 SOUTH AMERICA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 898 SOUTH AMERICA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 899 SOUTH AMERICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 900 SOUTH AMERICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 901 SOUTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 902 SOUTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 903 SOUTH AMERICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 904 SOUTH AMERICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 905 SOUTH AMERICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 906 SOUTH AMERICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 907 SOUTH AMERICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 908 SOUTH AMERICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 909 SOUTH AMERICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 910 SOUTH AMERICA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 911 SOUTH AMERICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 912 SOUTH AMERICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 913 SOUTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 914 SOUTH AMERICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 915 SOUTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 916 SOUTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 917 SOUTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 918 SOUTH AMERICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 919 SOUTH AMERICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 920 SOUTH AMERICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 921 SOUTH AMERICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 922 SOUTH AMERICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 923 SOUTH AMERICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 924 SOUTH AMERICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 925 SOUTH AMERICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 926 BRAZIL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 927 BRAZIL ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 928 BRAZIL SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 929 BRAZIL LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 930 BRAZIL SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 931 BRAZIL INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 932 BRAZIL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 933 BRAZIL CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 934 BRAZIL CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 935 BRAZIL CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 936 BRAZIL SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 937 BRAZIL INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 938 BRAZIL OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 939 BRAZIL OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 940 BRAZIL OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 941 BRAZIL LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 942 BRAZIL SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 943 BRAZIL NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 944 BRAZIL TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 945 BRAZIL TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 946 BRAZIL TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 947 BRAZIL SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 948 BRAZIL LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 949 BRAZIL SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 950 BRAZIL IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 951 BRAZIL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 952 BRAZIL ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 953 BRAZIL OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 954 BRAZIL PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 955 BRAZIL NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 956 BRAZIL DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 957 BRAZIL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 958 REST OF SOUTH AMERICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 959 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY COUNTRY, 2018-2027 (USD BILLION)

TABLE 960 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 961 MIDDLE EAST AND AFRICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 962 MIDDLE EAST AND AFRICA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 963 MIDDLE EAST AND AFRICA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 964 MIDDLE EAST AND AFRICA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 965 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 966 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 967 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 968 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 969 MIDDLE EAST AND AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 970 MIDDLE EAST AND AFRICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 971 MIDDLE EAST AND AFRICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 972 MIDDLE EAST AND AFRICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 973 MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 974 MIDDLE EAST AND AFRICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 975 MIDDLE EAST AND AFRICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 976 MIDDLE EAST AND AFRICA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 977 MIDDLE EAST AND AFRICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 978 MIDDLE EAST AND AFRICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 979 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 980 MIDDLE EAST AND AFRICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 981 MIDDLE EAST AND AFRICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 982 MIDDLE EAST AND AFRICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 983 MIDDLE EAST AND AFRICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 984 MIDDLE EAST AND AFRICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 985 MIDDLE EAST AND AFRICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 986 MIDDLE EAST AND AFRICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 987 MIDDLE EAST AND AFRICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 988 MIDDLE EAST AND AFRICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 989 MIDDLE EAST AND AFRICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 990 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 991 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 992 SOUTH AFRICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 993 SOUTH AFRICA ORAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 994 SOUTH AFRICA SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 995 SOUTH AFRICA LIQUID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 996 SOUTH AFRICA SEMI-SOLID ORAL DRUGS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 997 SOUTH AFRICA INJECTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 998 SOUTH AFRICA INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 999 SOUTH AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY MATERIAL, 2018-2027 (USD BILLION)

TABLE 1000 SOUTH AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE 2018-2027 (USD BILLION)

TABLE 1001 SOUTH AFRICA CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 1002 SOUTH AFRICA SELF-INJECTION DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY USABILITY, 2018-2027 (USD BILLION)

TABLE 1003 SOUTH AFRICA INJECTABLE DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1004 SOUTH AFRICA OPHTHALMIC DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1005 SOUTH AFRICA OCULAR DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1006 SOUTH AFRICA OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 1007 SOUTH AFRICA LIQUID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 1008 SOUTH AFRICA SEMI-SOLID OCULAR DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 1009 SOUTH AFRICA NASAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1010 SOUTH AFRICA TOPICAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1011 SOUTH AFRICA TRANSDERMAL DRUG DELIVERY DEVICES IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1012 SOUTH AFRICA TRANSDERMAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY FORM, 2018-2027 (USD BILLION)

TABLE 1013 SOUTH AFRICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 1014 SOUTH AFRICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 1015 SOUTH AFRICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS IN DRUG DELIVERY MARKET, BY TYPE, 2018-2027 (USD BILLION)

TABLE 1016 SOUTH AFRICA IMPLANTABLE DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1017 SOUTH AFRICA TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1018 SOUTH AFRICA ORAL TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1019 SOUTH AFRICA OTHER TRANSMUCOSAL DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1020 SOUTH AFRICA PULMONARY DRUG DELIVERY IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1021 SOUTH AFRICA NEBULIZERS IN DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

TABLE 1022 SOUTH AFRICA DRUG DELIVERY MARKET, BY END USER, 2018-2027 (USD BILLION)

TABLE 1023 SOUTH AFRICA DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD BILLION)

TABLE 1024 REST OF MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2018-2027 (USD BILLION)

Abbildungsverzeichnis

FIGURE 1 GLOBAL DRUG DELIVERY MARKET: SEGMENTATION

FIGURE 2 GLOBAL DRUG DELIVERY MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL DRUG DELIVERY MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL DRUG DELIVERY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL DRUG DELIVERY MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL DRUG DELIVERY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL DRUG DELIVERY MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL DRUG DELIVERY MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 GLOBAL DRUG DELIVERY MARKET: SEGMENTATION

FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL DRUG DELIVERY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027

FIGURE 11 RISING PREVALENCE OF CHRONIC DISEASES AND NON CHRONIC DISEASES AND GROWTH IN THE DEVELOPMENT OF BIOLOGICS ARE EXPECTED TO BE KEY DRIVING FACTORS IN THE GLOBAL DRUG DELIVERY MARKET IN THE FORECAST PERIOD OF 2020 TO 2027

FIGURE 12 ORAL DRUG DELIVERY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL DRUG DELIVERY MARKET IN 2020 & 2027

FIGURE 13 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR DRUG DELIVERY MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL DRUG DELIVERY MARKET

FIGURE 15 GLOBAL DRUG DELIVERY MARKET: BY PRODUCT TYPE, 2019

FIGURE 16 GLOBAL DRUG DELIVERY MARKET: BY PRODUCT TYPE, 2019-2027 (USD BILLION)

FIGURE 17 GLOBAL DRUG DELIVERY MARKET: BY PRODUCT TYPE, CAGR (2020-2027)

FIGURE 18 GLOBAL DRUG DELIVERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 19 GLOBAL DRUG DELIVERY MARKET: BY END USER, 2019

FIGURE 20 GLOBAL DRUG DELIVERY MARKET: BY END USER, 2019-2027 (USD BILLION)

FIGURE 21 GLOBAL DRUG DELIVERY MARKET: BY END USER, CAGR (2020-2027)

FIGURE 22 GLOBAL DRUG DELIVERY MARKET: BY END USER, LIFELINE CURVE

FIGURE 23 GLOBAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, 2019

FIGURE 24 GLOBAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)

FIGURE 25 GLOBAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)

FIGURE 26 GLOBAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 27 GLOBAL DRUG DELIVERY MARKET: SNAPSHOT (2019)

FIGURE 28 GLOBAL DRUG DELIVERY MARKET: BY REGION (2019)

FIGURE 29 GLOBAL DRUG DELIVERY MARKET: BY REGION (2020 & 2027)

FIGURE 30 GLOBAL DRUG DELIVERY MARKET: BY REGION (2019 & 2027)

FIGURE 31 GLOBAL DRUG DELIVERY MARKET: BY PRODUCT TYPE (2020-2027)

FIGURE 32 NORTH AMERICA DRUG DELIVERY MARKET: SNAPSHOT (2019)

FIGURE 33 NORTH AMERICA DRUG DELIVERY MARKET: BY COUNTRY (2019)

FIGURE 34 NORTH AMERICA DRUG DELIVERY MARKET: BY COUNTRY (2020 & 2027)

FIGURE 35 NORTH AMERICA DRUG DELIVERY MARKET: BY COUNTRY (2019 & 2027)

FIGURE 36 NORTH AMERICA DRUG DELIVERY MARKET: BY PRODUCT TYPE (2020-2027)

FIGURE 37 EUROPE DRUG DELIVERY MARKET: SNAPSHOT (2019)

FIGURE 38 EUROPE DRUG DELIVERY MARKET: BY COUNTRY (2019)

FIGURE 39 EUROPE DRUG DELIVERY MARKET: BY COUNTRY (2020 & 2027)

FIGURE 40 EUROPE DRUG DELIVERY MARKET: BY COUNTRY (2019 & 2027)

FIGURE 41 EUROPE DRUG DELIVERY MARKET: BY PRODUCT TYPE (2020-2027)

FIGURE 42 ASIA-PACIFIC DRUG DELIVERY MARKET: SNAPSHOT (2019)

FIGURE 43 ASIA-PACIFIC DRUG DELIVERY MARKET: BY COUNTRY (2019)

FIGURE 44 ASIA-PACIFIC DRUG DELIVERY MARKET: BY COUNTRY (2020 & 2027)

FIGURE 45 ASIA-PACIFIC DRUG DELIVERY MARKET: BY COUNTRY (2019 & 2027)

FIGURE 46 ASIA-PACIFIC DRUG DELIVERY MARKET: BY PRODUCT TYPE (2020-2027)

FIGURE 47 SOUTH AMERICA DRUG DELIVERY MARKET: SNAPSHOT (2019)

FIGURE 48 SOUTH AMERICA DRUG DELIVERY MARKET: BY COUNTRY (2019)

FIGURE 49 SOUTH AMERICA DRUG DELIVERY MARKET: BY COUNTRY (2020 & 2027)

FIGURE 50 SOUTH AMERICA DRUG DELIVERY MARKET: BY COUNTRY (2019 & 2027)

FIGURE 51 SOUTH AMERICA DRUG DELIVERY MARKET: BY PRODUCT TYPE (2020-2027)

FIGURE 52 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET: SNAPSHOT (2019)

FIGURE 53 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET: BY COUNTRY (2019)

FIGURE 54 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET: BY COUNTRY (2020 & 2027)

FIGURE 55 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET: BY COUNTRY (2019 & 2027)

FIGURE 56 MIDDLE EAST AND AFRICA DRUG DELIVERY MARKET: BY PRODUCT TYPE (2020-2027)

FIGURE 57 GLOBAL DRUG DELIVERY MARKET: COMPANY SHARE 2019 (%)

FIGURE 58 NORTH AMERICA DRUG DELIVERY MARKET: COMPANY SHARE 2019 (%)

FIGURE 59 EUROPE DRUG DELIVERY MARKET: COMPANY SHARE 2019 (%)

FIGURE 60 ASIA-PACIFIC DRUG DELIVERY MARKET: COMPANY SHARE 2019 (%)

Detaillierte Informationen anzeigen

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

What is the future market value for Drug Delivery Market?

The market value for Drug Delivery Market is expected USD 2800.61 million by 2029.

What is the growth rate of the Drug Delivery Market?

The Drug Delivery Market is to grow at a CAGR of 8.50% during the forecast by 2029

Which are the major market drivers for Drug Delivery Market?

The expansion of the Global Drug Delivery Market will be fueled by the rising demand for biosimilars and biologics and rising prevalence of chronic diseases. Additionally, increasing expenditure on healthcare infrastructure and increasing geriatric population will enhance the growth rate of global drug delivery market.

Who are the major players operating in the Drug Delivery Market?

The major players operating in the Drug Delivery Market are F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Bausch Health Companies Inc. (Canada), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Merck & Co., Inc. (US), Cadila Pharmaceuticals. (India), Dr. Reddy's Laboratories Ltd. (India), 3M (US), Bayer AG (Germany), Astellas Pharma Inc. (Japan), AbbVie Inc. (US), Takeda Pharmaceutical Company Limited (Japan).

Globaler Markt für Arzneimittelverabreichung – Branchentrends und Prognose bis 2029

Globaler Markt für Arzneimittelverabreichung – Branchentrends und Prognose bis 2029

Global Drug Delivery Market

CAGR : 8.50 %

Marktdynamik für Arzneimittelverabreichung

Auswirkungen von COVID-19 auf den Arzneimittelverabreichungsmarkt

Globaler Marktumfang für Arzneimittelverabreichung

Regionale Analyse/Einblicke zum Arzneimittelverabreichungsmarkt

Wettbewerbsumfeld und Analyse der Marktanteile im Bereich Arzneimittelverabreichung

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Inhaltsverzeichnis

Tabellenverzeichnis

Abbildungsverzeichnis

Forschungsmethodik

Anpassung möglich

Häufig gestellte Fragen

Berichte

Markteinblicke

Unterstützung

Lösungen

Globaler Markt für Arzneimittelverabreichung – Branchentrends und Prognose bis 2029

Globaler Markt für Arzneimittelverabreichung – Branchentrends und Prognose bis 2029

Global Drug Delivery Market

CAGR : 8.50 %

Marktdynamik für Arzneimittelverabreichung

Auswirkungen von COVID-19 auf den Arzneimittelverabreichungsmarkt

Globaler Marktumfang für Arzneimittelverabreichung

Regionale Analyse/Einblicke zum Arzneimittelverabreichungsmarkt

Wettbewerbsumfeld und Analyse der Marktanteile im Bereich Arzneimittelverabreichung

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Inhaltsverzeichnis

Tabellenverzeichnis

Abbildungsverzeichnis

Forschungsmethodik

Anpassung möglich

Häufig gestellte Fragen

Verwandte Seiten durchsuchen